Anca M. Avram is Professor of Radiology at the University of Michigan, Ann Arbor, USA where she currently serves as Director of the Nuclear Medicine Therapy Program. Dr. Avram’s clinical interests include radioactive iodine treatment for hyperthyroidism, thyroid cancer and radioimmunotherapy for lymphoma. Her research focuses on the role of diagnostic radioiodine imaging for guiding 131-I treatment for thyroid cancer, and clinical dosimetry protocols for metastatic thyroid cancer.

Dr. Avram received her medical degree from Carol Davila University of Medicine and Pharmacy followed by residencies in Plastic and Reconstructive Surgery from Plastic and Reconstructive Surgery and Burns Hospital; Internal medicine from Fairview Hospital Ohio; and Endocrinology, Diabetes, Metabolism from University of Michigan Health System. She also completed her fellowship in Nuclear Medicine from University of Michigan Health System.

Dr. Avram is certified by the American Board of Internal Medicine; the American Board of Endocrinology & Metabolism, and the American Board of Nuclear Medicine. She is a member of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Endocrine Society. Due to her nationally recognized expertise in the field of thyroid cancer, Dr. Avram has been an invited speaker for SNMMI;  American Thyroid Association (ATA) and the Japanese Society of Nuclear Medicine.

Representative Publications:

Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What is the Impact on Staging?

Thyroid Cancer in Children

Thyroid Cancer Recurrence in the Hilo Trial

Choroidal and Skin Metastases From Papillary Thyroid Cancer: Case And a Review of the Literature

Share

Discuss in Social Wall

Twitter

Share to rareTeam

myBinder